Production (Stage)
Restart Life Sciences Corp.
HEAL
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -570.50K | 100.00 | 336.90K | -66.20K | -107.10K |
| Total Depreciation and Amortization | 300.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 419.30K | -1.10K | -421.30K | -- | -- |
| Change in Net Operating Assets | -13.00K | -7.50K | 80.70K | 58.60K | 72.30K |
| Cash from Operations | -163.90K | -8.10K | -3.30K | -7.10K | -34.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 15.00K | 0.00 | 0.00 | 60.00K |
| Total Debt Repaid | -83.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 550.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 325.40K | 10.70K | 0.00 | 0.00 | 44.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.40K | 2.60K | -3.30K | -7.10K | 10.20K |